Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Point and Frameshift Mutations01:30

Point and Frameshift Mutations

36
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
36
Homologous Recombination02:31

Homologous Recombination

50.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.7K
RNA Editing02:23

RNA Editing

9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variant-to-gene mapping identifies <i>ARHGEF12</i> as a primary open-angle glaucoma effector gene operating within retinal ganglion cells.

bioRxiv : the preprint server for biology·2026
Same author

Bilateral retinal rescue through unilateral AAV8-CYP4V2 gene delivery in Bietti crystalline dystrophy.

Molecular therapy. Methods & clinical development·2025
Same author

Prime editing for the investigation of aberrant splicing defect associated with a pathogenic <i>PRPH2</i> variant.

Molecular therapy. Nucleic acids·2025
Same author

Eyes shut homolog (EYS): Connecting molecule to disease.

Progress in retinal and eye research·2025
Same author

Best Vitelliform Macular Dystrophy.

Advances in experimental medicine and biology·2025
Same author

Enhanced S-Cone Syndrome (Goldmann-Favre Syndrome).

Advances in experimental medicine and biology·2025

Related Experiment Video

Updated: Jul 23, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K

Prime Editing Strategy to Install the PRPH2 c.828+1G>A Mutation.

Salvatore Marco Caruso1,2,3, Yi-Ting Tsai1, Bruna Lopes da Costa1,2,3

  • 1Department of Biomedical Engineering, Columbia University, New York, NY, USA.

Advances in Experimental Medicine and Biology
|July 13, 2023
PubMed
Summary

Mutations in peripherin 2 (PRPH2) cause inherited retinal diseases. Researchers developed a prime editing method to precisely insert a PRPH2 mutation into stem cells for disease modeling.

Keywords:
Disease modelingPRPH2Prime editingRDSiPSC

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

7.7K

Related Experiment Videos

Last Updated: Jul 23, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

7.7K

Area of Science:

  • Genetics
  • Ophthalmology
  • Stem Cell Biology

Background:

  • Peripherin 2 (PRPH2) mutations are linked to inherited retinal diseases (IRDs) like retinitis pigmentosa (RP) and macular degeneration.
  • PRPH2 is crucial for photoreceptor outer segment structure; mutations cause outer segment disorganization or absence.
  • A patient with PRPH2-linked RP presented with widespread retinal pigment epithelium (RPE) atrophy, notably sparing the fovea.

Purpose of the Study:

  • To establish an efficient method for introducing specific mutations into induced pluripotent stem cells (iPSCs) for modeling rare genetic eye diseases.
  • To develop a prime editing strategy for accurately inserting the pathogenic PRPH2 c.828+1 G>A splice-site mutation into wild-type iPSCs.
  • To facilitate the generation of well-laminated retinal organoids for studying the pathobiology of PRPH2-based RP.

Main Methods:

  • Development of a prime editing system tailored for precise genetic modification.
  • Application of the prime editing strategy to introduce the c.828+1 G>A splice-site mutation in the PRPH2 gene.
  • Utilizing engineered iPSCs to generate retinal organoids for disease modeling.

Main Results:

  • An efficient prime editing strategy was successfully developed and implemented.
  • The pathogenic PRPH2 c.828+1 G>A splice-site mutation was accurately installed in iPSCs.
  • The developed method enables the generation of iPSC-derived retinal organoids carrying specific disease-causing mutations.

Conclusions:

  • Prime editing offers an effective approach for introducing specific mutations into iPSCs for modeling rare genetic disorders.
  • This strategy is crucial for advancing the study of PRPH2-linked inherited retinal diseases using iPSC-derived retinal organoids.
  • The developed method holds promise for creating accurate disease models to investigate the pathobiology and potential therapies for IRDs.